CClinicalTrials.gg
CompletedNCT01063738REMAICUpdated Oct 3, 2019

Rehabilitating Muscle After Intensive Care

An interventional study of Amino acid supplement and PEPSE in Recovery From Critical Illness, sponsored by St Helens & Knowsley Teaching Hospitals NHS Trust. Completed at 2 sites in United Kingdom. Open to participants aged 45 Years to 99 Years. Per ClinicalTrials.gov, last updated 2019-10-03.

Sponsored by St Helens & Knowsley Teaching Hospitals NHS Trust · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
45 Years to 99 Years
Sex
All
01

Study summary

The study will examine the effect of amino acid supplements and enhanced physiotherapy on physical recovery following critical illness in intensive care.

Read the detailed description

Critically ill patients aged 45 years and over will be recruited during recovery after intensive care. Using a randomised controlled, blind at follow-up design the study will examine whether the combination of an amino acid supplement and an enhanced physiotherapy programme improve the rehabilitation of muscle following intensive care better than a self-guided rehabilitation programme alone or with either an amino acid supplement or the enhanced physiotherapy programme. The Primary efficacy outcome will be the improvement in six minute walking test measured at 3 months post intensive care discharge. Secondary efficacy parameters will be insulin resistance, health related quality of life and muscle mass using DEXA scanning at 3 months and 1 year post intensive care discharge.

02

Conditions studied

  • Recovery From Critical Illness

Browse trials for

Keywords

  • Rehabilitation
  • Intensive Care
  • Critical illness
  • Physiotherapy
  • Nutritional supplementation
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 93 is close to the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

St Helens & Knowsley Teaching Hospitals NHS Trust is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 45 years of age and over with an intensive care stay of five days or more

Exclusion criteria

Exclusion Criteria:

  • Physically not capable of engaging with the practical requirements of the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
93 participants (actual)

Study arms

  • Active comparator
    ICU Recovery Manual & placebo supplement

    Patients will receive the standard self-directed rehabilitation package and a placebo nutritional supplement

    Other: Intensive Care Unit (ICU) Recovery Manual · Dietary Supplement: Placebo nutritional supplement

  • Experimental
    ICU recovery manual & amino acid (AA) supplement

    Patients will receive the standard self-directed rehabilitation package with the essential amino acid supplement

    Dietary Supplement: Amino acid supplement · Other: Intensive Care Unit (ICU) Recovery Manual

  • Experimental
    PEPSE & placebo supplement

    Patients will receive the standard self-directed rehabilitation package plus PEPSE and the placebo nutritional supplement

    Other: PEPSE · Other: Intensive Care Unit (ICU) Recovery Manual · Dietary Supplement: Placebo nutritional supplement

  • Experimental
    PEPSE & AA supplement

    Patients will receive the standard self-directed rehabilitation package plus PEPSE and the essential amino acid nutritional supplement

    Dietary Supplement: Amino acid supplement · Other: PEPSE · Other: Intensive Care Unit (ICU) Recovery Manual

Interventions

  • Dietary supplementAmino acid supplement

    Flavoured essential amino acid supplement and glutamine dipeptide taken twice daily for 3 months

  • OtherPEPSE

    Enhanced physiotherapy programme of 3 1 hour sessions per week for 6 weeks while in hospital and once discharged home 1 supervised outpatient session of 1 hour and 2 home exercise sessions per week (PEPSE).

  • OtherIntensive Care Unit (ICU) Recovery Manual

    Standard self-directed 6 week rehabilitation package

  • Dietary supplementPlacebo nutritional supplement

    Cherry flavoured low calorie and low protein placebo drink

06

What researchers measure

Primary outcomes

  1. The change in the distance walked by patients in 6 minutes (6 minute walk test) between recruitment to the study and 3 months post intensive care discharge

    Time frame: 3 months

Secondary outcomes

  1. Improvement in insulin resistance between recruitment to the study and the 1 year follow-up point

    Time frame: 1 year

  2. Improvement in patients perception of their health related quality of life between recruitment to the study and the 1 year follow-up point

    Time frame: 1 year

  3. Increase in muscle mass and bone density assessed using dual energy x-ray absorptiometry (DEXA) scanning between recruitment to the study and the 1 year follow-up point

    Time frame: 1 year

07

Study locations

2 sites
  • St Helens & Knowsley Teaching NHS Trust
    Prescot, Merseyside L35 5DR, United Kingdom
  • Central Manchester University Hospitals NHS Foundation Trust
    Manchester, M13 9WL, United Kingdom
08

References and documents

Publications

  • Jones C, Eddleston J, McCairn A, Dowling S, McWilliams D, Coughlan E, Griffiths RD. Improving rehabilitation after critical illness through outpatient physiotherapy classes and essential amino acid supplement: A randomized controlled trial. J Crit Care. 2015 Oct;30(5):901-7. doi: 10.1016/j.jcrc.2015.05.002. Epub 2015 May 9. PubMed 26004031 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01063738
Lead sponsor
St Helens & Knowsley Teaching Hospitals NHS Trust
Collaborators
Manchester University NHS Foundation Trust
Responsible party
Sponsor
First posted
Feb 5, 2010
Start date
Aug 2010
Primary completion
Mar 2014
Completion
Nov 2014
Last update
Oct 3, 2019

Study contacts

Richard D Griffiths, MD
principal investigator · St Helens & Knowley Teaching NHS Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion